Yoga for Overactive Bladder
Trial Summary
The trial protocol does not specify whether participants need to stop taking their current medications. It seems that participants will continue their standard care while not in the active treatment arm.
Research suggests that yoga and mindfulness programs can help improve symptoms of urinary incontinence and lower urinary tract issues, which are related to overactive bladder. A study comparing mindfulness-based stress reduction and yoga found improvements in urinary urge incontinence, and a review indicated that yoga can enhance the functioning of the lower urinary tract.
12345A review of 94 studies involving 8,430 participants found no significant differences in serious or nonserious adverse events between yoga and usual care or exercise, suggesting that yoga is generally safe for humans.
13567Yoga for overactive bladder is unique because it combines physical postures, breathing exercises, and meditation to improve mental and physical well-being, unlike standard medical treatments that often involve medication or surgery. This mind-body approach can enhance relaxation and stress resilience, potentially reducing bladder symptoms without the side effects associated with drugs.
89101112Eligibility Criteria
This trial is for children and teenagers aged 8-18 with idiopathic overactive bladder, who have a specific score indicating the condition's severity. They must be able to give consent or have it provided by a guardian. Those with untreated urinary tract abnormalities, neurogenic bladder conditions, nerve damage affecting pelvic function, or recent toxin treatments for the bladder are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants take part in a weekly yoga session for a total of 6 weeks, with validated questionnaires and urinary samples for biomarkers completed at the beginning, middle, and end of the study
Follow-up
Participants are monitored for changes in overactive bladder symptoms and urinary biomarkers